US/UK/Canada

Share

Contacts

  • Jenny Styren

    Chief Marketing & Communication Officer


    +46 703793483

    • Quotes

    We are truly excited about the possibilities of being able to welcome FRISQ, its employees, partners and customers to Cambio. The portfolio of FRISQ will fill a very important part of our offering going forward but more importantly we will add lots of new, fantastic talent across the board of our business. Now our focus will be on completing the Due Diligence and conclude the transaction during Q3
    Rami Avidan, CEO, Cambio
    Pick a time period -
    Tags ( Active)

    Sanolium AB – Approval of written procedure

    Sanolium AB (publ) (the "Company" and together with its subsidiaries the "Group") today announces the successful completion of the written procedure that was initiated on 17 June 2026 (the "Written Procedure") in relation to the Company's up to SEK 1,500,000,000 senior secured callable floating rate bonds with ISIN SE0021628237 (the "Bonds").The Issuer has requested that holders of the Bonds to vote in favour of a temporary increase of the commitments under the revolving facility under the Company's super senior facility agreement and a corresponding temporary increase of the super senior

    Sanolium AB initiates a written procedure

    Sanolium AB (publ) (the "Company" and together with its subsidiaries the "Group"), has instructed Nordic Trustee & Agency AB (publ), the agent for the Company's up to SEK 1,500,000,000 senior secured callable floating rate bonds with ISIN SE0021628237 (the "Bonds") to initiate a written procedure to request the bondholders to vote in favour of a temporary increase of the commitments under the revolving facility under the Company's super senior facility agreement and a corresponding temporary increase of the super senior headroom under the intercreditor agreement, as further specified in the

    Cambio interim report Q1 2026

    Cambio continued to execute on its strategy to enable tomorrow’s health and social care, today. During the first quarter, revenue increased by 3% year-on-year to 331 MSEK. Adjusted EBITDA amounted to 29 MSEK, reflecting continued investments in delivery capacity, product development and customer commitments as we move into the next phase of several large-scale customer deliveries.Financial highlights for the 1st quarter of 2026: · Revenue amounted to 331.3 (320.6) MSEK in the first quarter, representing growth of 3.3% · Adjusted EBITDA amounted to 29.2 (41.2) MSEK · Income before

    Cambio interim report Q4 2025

    Cambio delivers strong growth and key strategic progress in Q4 2025 Cambio delivered a strong fourth quarter with solid financial performance and major strategic progress. Revenue grew 34% to 458 MSEK and Adjusted EBITDA more than doubled to 163 MSEK. For the full year, revenue increased 16% to 1,379 MSEK and profitability strengthened further. A key milestone was the agreement with Region Stockholm and Region Gotland, confirming long‑term trust in Cambio COSMIC as a mission‑critical EHR platform. Operationally, the company completed go‑lives in Region Blekinge and Region Dalarna,

    Cambio interim report Q3 2025

    Cambio continues to execute on our strategy to enable tomorrow’s health and social care, today. During the quarter we reached two important milestones. First, Region Sörmland went live within the Sussa collaboration in September, which means eight out of the nine Sussa regions are now operating on Cambio COSMIC. Second, we went live in Finland with our customer Åland in September, including the local municipalities. This marked a swift implementation from contract award in Q2 2024 to go-live just over a year later and further strengthened our Nordic footprint.Quarterly highlights, July -

    Region Stockholm and Region Gotland signs agreement with Cambio

    Region Stockholm and Region Gotland have signed an agreement with Cambio for the delivery of the main electronic health record system, Cambio COSMIC. The implementation means that the regions will have access to a modern and well-proven system, which is a central part of the healthcare sector’s digital infrastructure. The joint work to implement Cambio COSMIC now begins and is an important step in accelerating the digital transformation within health and social care.“We are proud and delighted by the region’s decision to choose Cambio as a partner for digitising healthcare. The electronic

    Cambio interim report Q2 2025

    During the second quarter we continued to execute on our strategy to enable tomorrow’s health and social care, today. The team delivered against key milestones in our largest programmes while strengthening our offering through focused innovation.Within the Sussa collaboration, Region Västerbotten went live with Cambio COSMIC. As one of Northern Europe’s most important healthcare IT programmes, the implementation in the Sussa regions continues to demonstrate the scalability of our platform and the strength of our partnership model across regions. Outside Sweden, we reached a planned

    Technical Operating Environment Delivered – Key Milestone in Åland’s Implementation of Cambio COSMIC

    The implementation of the healthcare information system Cambio COSMIC in Åland has reached a significant milestone. The technical operating environment, which forms the foundation for the system’s upcoming deployment, has now been delivered and approved by ÅHS, Åda, and the municipalities. This marks a crucial step in one of Åland’s most comprehensive digitalisation projects, aiming to create a modern, secure, and efficient system that strengthens the entire health and social care sector in Åland.Cambio COSMIC will play a central role in modernising healthcare and social services, enhancing

    Cambio Interim Report Q1 2025

    Cambio continues to make strong progress in our mission to support the digital transformation of healthcare and social care across Sweden and the Nordics. During the first quarter of 2025, we successfully went live in three additional Sussa regions – Gävleborg, Västernorrland and Halland – further expanding the reach of Cambio COSMIC as the main Electronic Health Record (EHR) solution in Sweden. After the end of the quarter, we also went live in Region Västerbotten. These go-lives are the result of close collaboration with our regional partners and are a testament to the strength and

    Cambio acquires Leapscribe, an ambient scribe-company, taking an important step toward more efficient healthcare

    Cambio, a leading provider of eHealth solutions in the Nordics, is acquiring the innovation company Leapscribe. The company has developed an AI assistant that automatically generates medical notes during patient consultations, freeing up time and simplifying work for healthcare professionals without compromising patient safety or privacy. The goal is for the AI-assistant to become an integral part of the electronic health record (EHR) system Cambio COSMIC. The acquisition aligns with Cambio’s ambition to drive the development of a digital ecosystem for smarter and more patient-centered care.

    Cambio Interim Report Q4 2024

    Cambio has continued to go live with additional Sussa regions. On November 23[rd], Norrbotten became the 10[th] region in Sweden and the 2[nd] in the Sussa customer group to utilize Cambio COSMIC as their main Electronic Health Records solution. After the fourth quarter, in January 2025, Region Gävleborg was added to the regions that are live. While large IT implementations are complex, and thousands of hours went into preparations, the implementation in the regions have shown the strength of the Cambio offering. Each region has driven its own implementation process, with support from Cambio.

    Cambio receives MDR certification for EHR-system and clinical decision support

    Cambio's electronic health record system Cosmic and their solution for clinical decision support (CDS) have now been registered and certified according to MDR, the Medical Device Regulation. This means that the products are approved and CE-marked in accordance with the EU regulation on medical devices, which ensures the safety and performance of medical equipment. "The MDR certification is an important milestone for us as a company, and I am very proud of the work we have done together at Cambio. The certification is proof that those who use our products can trust that they meet the

    Cambio Interim Report Q2 2024

    The previous quarter held a lot of progress for us at Cambio. Getting the confidence from Åland to be a part of their coming journey in healthcare with delivering our EHR-system Cosmic is a great testament to our strong offering to the market. Soon we will start off with the first of the Sussa regions to go live with Cambio Cosmic. Region Örebro will be the first of nine Swedish regions. Im humbled and proud over the fact that soon a majority of the healthcare provided in Sweden will be provided through Cambio COSMIC. At Cambio we continue to develop solutions, partnerships and innovation

    Sanolium interim report Q1 Jan-Mar 2024

    Today Sanolium releases the interim report for the first quarter this year“We have continued developing the company in line with our strategic direction during the first quarter 2024. Im proud to see such progress among our ongoing projects as well as the trust from new customers as we continue on the journey towards a healthier tomorrow,” says Rami Avidan, CEO of Cambio A number of important steps has been taken during Q1: · Frame agreement with Karolinska Institute · Continued preparations for the go live with Sussa, one of the largest IT healthcare projects in Europe ·

    Sanolium publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm

    Sanolium AB (publ) (the "Company" or "Sanolium") has issued a senior secured bond loan of SEK 1,000,000,000 on 15 March 2024, within a total framework amount of SEK 1,500,000,000, on the Swedish bond market (the "Bonds"). The Bonds carry a floating interest rate of STIBOR 3m + 4.00 per cent. per annum and matures 15 March 2029. The Company will apply for listing of the Bonds on the Corporate Bond list at Nasdaq Stockholm. The Bonds will be admitted to trading at Nasdaq Stockholm as soon as possible. In connection with this, the Company has prepared a prospectus. The prospectus has

    Sanolium announces that the condition for the early redemption of its outstanding 2019/2024 bonds has been satisfied

    On 29 February 2024, Sanolium AB (publ) (the "Company" or "Sanolium") announced its intention to redeem in full the outstanding 2019/2024 bonds with ISIN SE0012596179 (the "Redemption" and the "Existing Bonds", respectively).The Redemption was conditional upon the Issuer's receipt of funds in connection with the issue of new floating rate senior secured bonds under a total framework of SEK 1,500 million, with a tenor of five years and an initial amount of SEK 1,000 million, as further described in the Company's press release on 29 February 2024 (the "Financing Condition" and the "New Bonds",

    Sanolium successfully announces results from the tender offer

    NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAWSanolium AB (publ) (the “Company” or “Sanolium”), being the parent company of the Cambio group, announces results of its tender offer (the “Tender Offer”) to the holders of Sanolium’s

    Sanolium successfully issued new senior secured bonds of SEK 1,000m

    NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAWSanolium AB (publ) (the “Company” or “Sanolium”), being the parent company of the Cambio group, has successfully issued senior secured bonds (the “New Bonds”) in an initial amount of SEK 1,

    Cambio Year End Report Q4 2023

    We had a strong fourth quarter, characterized by solid profitable growth and important customer wins. Customer Group KGC (Kundgrupp Cosmic), which consists of eight Swedish regions and one private care giver, has signed an extension of its COSMIC contract for another 5 years with 3 additional option years. This is a testament to the strong relationship between KGC and Cambio that has been developed over the last years. In the fourth quarter, we received a major order worth 84 MSEK to provide additional functionality to KGC, which will be delivered during 2023 and 2024. The order

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media

    Rss